Enteric fever, primarily caused by Salmonella typhi or Salmonella paratyphi, presents significant challenges to modern healthcare, particularly in developing countries. Effective management requires comprehensive strategies that encompass prevention, timely diagnosis, and appropriate treatment.
Prevention remains the cornerstone of enteric fever management. This includes improving sanitation and access to clean drinking water, food safety measures, and vaccination. Typhoid conjugate vaccines (TCVs) have shown promising results, with WHO recommending their use in endemic areas.
Early and accurate diagnosis is pivotal. Conventional methods like blood culture remain the gold standard but suffer from low sensitivity. Newer diagnostic techniques, such as molecular methods and serological tests, offer improved sensitivity and specificity, albeit at a higher cost.
Treatment primarily involves antibiotic therapy. However, the emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains necessitates careful antibiotic selection. Current guidelines recommend third-generation cephalosporins or fluoroquinolones for uncomplicated cases and carbapenems for severe or MDR/XDR cases. Patient monitoring and supportive care are also crucial.
Antimicrobial resistance (AMR) is a significant concern in enteric fever management. Strategies to combat AMR include surveillance for drug-resistant strains, antibiotic stewardship programs, and research into novel antimicrobials and alternative therapies.
In conclusion, effective management of enteric fever necessitates a comprehensive, multi-faceted approach. Preventive measures, improved diagnostics, appropriate treatment protocols, and strategies to address AMR are all integral components. As healthcare professionals, our role extends beyond treating individual patients to influencing public health policies and advocating for necessary resources to combat this global health threat.
1.
Rural colon cancer patients face higher risks, but minimally invasive surgery could narrow gap
2.
Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal
3.
Laryngeal Transplant Helped a Cancer Patient Speak Again in Pioneering Study
4.
The amount of liver tissue removed during gallbladder surgery has no discernible impact on overall survival.
5.
Long-Acting Interferon Therapy Approved for ET
1.
Molecular Network Mapping in Hematologic Disease
2.
Metabolic Reprogramming of the Tumor Microenvironment: Mechanisms, Clinical Relevance, and Emerging Therapeutic Strategies
3.
Hematopoietic Stem Cell Clonal Dynamics Across the Lifespan
4.
Connected Hematology Laboratory Networks for Automated Cross-Institution Data Exchange
5.
Digital Oncology Ecosystems Integrating Longitudinal Patient Trajectories: Transforming Cancer Care through Data-Driven Innovation
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
2.
Common side effects of cancer treatment and how they are managed
3.
Clinical Excellence in Hematology
4.
Best Practices in Hematology
5.
Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation